Ecoark Holdings, Inc. (OTCMKTS:EARK) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive
Ecoark Holdings, Inc. (OTCMKTS:EARK) Files An 8-K Entry into a Material Definitive Agreement Market Exclusive
US Warrant News
Key Energy Services' $242 Million Restructuring Procedure – Global Legal Chronicle
Key Energy Services’ $242 Million Restructuring Procedure Global Legal Chronicle
Key Energy Services' $242 Million Restructuring Procedure – Global Legal Chronicle Read More »
Maverix Metals: An Emerging Gold Royalty Opportunity – Seeking Alpha
Maverix Metals: An Emerging Gold Royalty Opportunity Seeking Alpha
Maverix Metals: An Emerging Gold Royalty Opportunity – Seeking Alpha Read More »
Selecta Biosciences, Inc. S-3 Jan. 29, 2020 4:46 PM – Seeking Alpha
Selecta Biosciences, Inc. S-3 Jan. 29, 2020 4:46 PM Seeking Alpha
Selecta Biosciences, Inc. S-3 Jan. 29, 2020 4:46 PM – Seeking Alpha Read More »
Form 8-K SOUTH STATE Corp For: Jan 25 – StreetInsider.com
Form 8-K SOUTH STATE Corp For: Jan 25 StreetInsider.com
Form 8-K SOUTH STATE Corp For: Jan 25 – StreetInsider.com Read More »
Form 425 BioPharmX Corp Filed by: BioPharmX Corp – StreetInsider.com
Form 425 BioPharmX Corp Filed by: BioPharmX Corp StreetInsider.com
Form 425 BioPharmX Corp Filed by: BioPharmX Corp – StreetInsider.com Read More »
Outlook Therapeutics Incs. (OTLK) PT Lowered to $11 at Oppenheimer – StreetInsider.com
Outlook Therapeutics Incs. (OTLK) PT Lowered to $11 at Oppenheimer StreetInsider.com
Outlook Therapeutics Incs. (OTLK) PT Lowered to $11 at Oppenheimer – StreetInsider.com Read More »
Reviewing Nuveen Municipal Value Fund (NYSE:NUV) & Equus Total Return (NYSE:EQS) – Riverton Roll
Reviewing Nuveen Municipal Value Fund (NYSE:NUV) & Equus Total Return (NYSE:EQS) Riverton Roll
Alliance Digital Fund secures EUR40m capital commitment from The Gem Group – Private Equity Wire
Alliance Digital Fund secures EUR40m capital commitment from The Gem Group Private Equity Wire
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Files An 8-K Entry into a Material Definitive Agreement Market Exclusive